Advertisement

Phytochemistry Reviews

, Volume 4, Issue 2–3, pp 159–175 | Cite as

Biological Activities and Chemistry of Saponins from Panax ginseng C. A. Meyer

  • Jong Dae Park
  • Dong Kwon Rhee
  • You Hui Lee
Open Access
Article

Abstract

The roots of Panax ginseng C. A. Meyer, known as Korean ginseng have been a valuable and important folk medicine in the East Asian countries, such as China, Korea and Japan for about 2000 years. Panax is derived from a word “panacea”, which means cure-all diseases and longevity as well as physical strength and resistance. As the use of traditional Chinese herbs as a food supply becomes more and more popular in the western countries, sales of Panax ginseng are increasing in North America and Europe as well as other parts of the world. Active constituents found in most ginseng species include ginsenosides, polysaccharides, peptides, polyacetylenic alcohols and fatty acids. Major active components in Panax ginseng are the ginsenosides, a group of saponins with triterpenoid dammarane structure. More than 30 ginsenosides have been isolated, and known compounds are identified but new compounds were elucidated. Pharmacological effects of ginseng have been demonstrated in cancer, diabetes mellitus, cardiovascular system, immune system and central nervous system including anti-stress and anti-oxidant activity. We have focused this review on the effect of ginseng on diabetes, anticancer activity and cardiovascular system and chemical structures of ginsenosides. In addition, our recent biological study on 20(S)-ginsenoside Rg3 is also touched upon as follows. Multidrug resistance (MDR) has been a major problem in cancer chemotherapy. In this study in vitro and in vivo modulations of MDR by 20(S)-ginsenoside Rg3 (Rg3), a saponin characteristic of red ginseng, was investigated. In flow cytometric analysis using rhodamine 123 as an artificial substrate, Rg3 promoted accumulation of rhodamine 123 in drug-resistant human fibrocarcinoma KBV 20C cells in a dose-dependent manner, but it had no effect on parental KB cells. Additionally Rg3 inhibited [3H]-vinblastine efflux and reversed MDR to DOX (doxorubicin), COL, VCR (vincristine) and VP-16 in KBV20C cells. Reverse transcriptase-polymerase chain reaction and immuno-blot analysis after exposure of KBV20C cells to Rg3 showed that inhibition of drug efflux by Rg3 was due to neither repression of MDR1 gene expression nor P-glycoprotein (Pgp) level. Photo-affinity labeling study with [3H]-azidopine, however, revealed that Rg3 competed with [3H]-azidopine for binding to the Pgp demonstrating that G-Rg3 competed with anticancer drug for binding to Pgp thereby blocking drug efflux. Furthermore, Rg3 increased life span in mice implanted with DOX-resistant murine leukemia P388 cells in vivo and inhibited body weight increase significantly. Further clinical trial of Rg3 in reversal of Pgp-associated MDR is highly feasible.

Keywords

active constituents anticancer antidiabetic antihypertensive activities Araliaceae biological activities ginsenosides metabolism multidrug resistance Panax ginseng saponin 

References

  1. Astrup, A, Finer, N 2000Redefining type 2 diabetes ‘diabesity’ or ‘obesity dependent diabetes mellitus’Obes. Rev.15759PubMedGoogle Scholar
  2. Atopkina, LN, Malinovskaya, GV, Elyakov, GB, Uvarova, NI, Woerdenbag, HJ, Koulman, A, Pras, N, Potier, P 1999Cytotoxicity of natural ginseng glycosides and semisynthetic analoguesPlanta Med.653034CrossRefPubMedGoogle Scholar
  3. Attele, AS, Zhou, YP, Xie, JT, Wu, JA, Zhang, L, Dey, L, Pugh, W, Rue, PA, Polonsky, KS, Yuan, CS 2002Antidiabetic effects of Panax ginseng berry extract and the identification of an effective componentDiabetes5118511858PubMedGoogle Scholar
  4. Bai, CX, Sunami, A, Namiki, T, Sawanobori, T, Furukawa, T 2003Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytesEur. J. Pharmacol.223544Google Scholar
  5. Bensky, D, Gamble, A 1993Chinese Herbal Medicine Materia MedicaEastland PressSeattle, WAGoogle Scholar
  6. Chung, SH, Choi, CG, Park, SH 2001Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy miceArch. Pharm. Res.24214218PubMedCrossRefGoogle Scholar
  7. Choi, CH, Kang, G, Min, YD 2003Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginsengPlanta Med.69235240CrossRefPubMedGoogle Scholar
  8. Duda, RB, Kang, SS, Archer, SY, Meng, S, Hordin, RA 2001American ginseng transcriptionally activates p21 mRNA in breast cancer cell linesJ. Korean Med. Sci.16S54S60PubMedGoogle Scholar
  9. Duda, RB, Taback, B, Kessel, B, Dooley, DD, Yang, H, Marchiori, J, Slomovic, BM, Alvarez, JG 1996pS2 expression induced by American ginseng in MCF-7 breast cancer cellsAnn. Surg. Oncol.3515520PubMedGoogle Scholar
  10. Duda, RB, Zhong, Y, Navas, V, Li, MZ, Toy, BR, Alavarez, JG 1999American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growthJ. Surg. Oncol.72230239CrossRefPubMedGoogle Scholar
  11. Friedberg, EC 1986Cancer BiologyW. H. Freeman and CompanyNew York138148Google Scholar
  12. Fujikawa-Yammamoto, K, Ota, T, Odashima, S, Abe, H, Arichi, S 1987Different response in the cell cycle of tumor cells to ginsenoside Rh2 Cancer J.1349352Google Scholar
  13. Fujimoto, J, Sakaguchi, H, Aoki, I, Toyoki, H, Khatun, S, Tamaya, T 2001Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membraneEur J. Gynaecol. Oncol.22339341PubMedGoogle Scholar
  14. Fukushima SH, Wanibuchi H & Li W (2001) Inhibition by ginseng of colon carcinogenesis in rats. J. Korean Med. Sci. S75–S80.Google Scholar
  15. Gillis CN, Kim HY, Chen X & Park H (1993) Pulmonary vascular effects of ginsenosides. Proceedings of 6th International Ginseng Symposium, pp. 36–39.Google Scholar
  16. Han, BH, Park, MH, Han, YN, Woo, LK, Sankawa, U, Yahara, S, Tanaka, O 1982Degradation of ginseng saponins under mild acidic conditionsPlanta Med.44146149PubMedGoogle Scholar
  17. Hasegawa, H, Benno, Y 2000aAnticarcinogenesis in mice by ginseng hydrolyzing colonic bacteriaMicrob. Ecol. Health Dis.128591CrossRefGoogle Scholar
  18. Hasegawa, H, Lee, KS, Nagaoka, T, Tezuka, Y, Uchiyama, M, Kadota, S, Saiki, I 2000bPharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esterBiol. Pharm. Bull.23298304Google Scholar
  19. Hasegawa, H, Saiki, I 2000cOleoyl triterpene glycoside biosynthesized from ginseng suppresses growth and metastasis of murine melanoma B16-F10 tumor via immunostimulationJ. Trad. Med.17186193Google Scholar
  20. Hasegawa, H, Sung, JH, Matsumiya, S, Uchiyama, M 1996Main ginseng saponin metabolites formed by intestinal bacteriaPlanta Med.62453457PubMedGoogle Scholar
  21. Hasegawa, H, Sung, JH, Matsumiya, S, Uchiyama, M, Inouye, Y, Kasai, R, Yamasaki, K 1995Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoidsPlanta Med.61409413PubMedGoogle Scholar
  22. Hasegawa, H, Suzuki, R, Nagaoka, T, Tezuka, Y, Kadota, S, Saiki, I 2002Prevention of growth and metastasis of murine melanoma through enhanced natural killer cytotoxicity by fatty acid conjugate of protopanxatriolBiol. Pharm. Bull.25861866CrossRefPubMedGoogle Scholar
  23. Hirai A (1999). Studies on the mechanisms of anti-platelet and anti-atherosclerotic effects of Korean red ginseng: Focusing on arachidonic acid cascade. Proceedings of ’99 Korea–Japan Ginseng Symposium, pp. 16–31.Google Scholar
  24. Huang, KC 1999The Pharmacology of Chinese HerbsCRC PressBoca Raton, FLGoogle Scholar
  25. Jeon, BH, Kim, CS, Park, KS, Lee, JW, Park, JB, Kim, KJ, Kim, SH, Chang, SJ, Nam, KY 2000Effect of Korea red ginseng on the blood pressure in conscious hypertensive ratsGen. Pharmacol.35135141PubMedGoogle Scholar
  26. Kang, SY, Schini-Kerth, VB, Kim, ND 1995Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aortaLife Sci.5615771586CrossRefPubMedGoogle Scholar
  27. Karikura, M, Miyase, T, Tanizawa, H, Taniyama, T, Takino, Y 1991aStudies on absorption, distribution, excretion and metabolism of ginseng saponins. VI. The decomposition products of ginsenoside Rb2 in the stomach of ratsChem. Pharm. Bull. (Tokyo)39400404Google Scholar
  28. Karikura, M, Miyase, T, Tanizawa, H, Taniyama, T, Takino, Y 1991bStudies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of ratsChem. Pharm. Bull. (Tokyo)3923572361Google Scholar
  29. Kasai, R, Besso, H, Tanaka, O, Saruwatari, YI, Mizutare, T 1983Saponins of red ginsengChem. Pharm. Bull.3121202125Google Scholar
  30. Kim YS, Jin SH, Lee YH, Kim SI & Park JD (1999a) Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL or Bax in C6Bu-1 cells. Proceedings of ’99 Korea–Japan Ginseng Symposium, pp. 150–162.Google Scholar
  31. Kim, ND, Kang, SY, Kim, MJ, Park, JH, Schini-Kerth, VB 1999bThe ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: Role of K+ channelsEur. J. Pharmacol.3675157Google Scholar
  32. Kim, ND, Kang, SY, Park, JH, Schini-Kerth, VB 1999cGinsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: Role of K+ channelsEur. J. Pharmacol.3674149Google Scholar
  33. Kim, ND, Kang, SY, Schini, VB 1994Ginsenosides evoke endothelium-dependent vascular relaxation in rat aortaGen. Pharmacol.2510711077PubMedGoogle Scholar
  34. Kim, YS, Kim, DS, Kim, SI 1998Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: Modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2Int. J. Biochem. Cell Biol.3027338Google Scholar
  35. Kim, SW, Kwon, HY, Chi, DW, Shim, JH, Park, JD, Lee, YH, Pyo, S, Rhee, DK 2003Reversal of P- glycoprotein-mediated multidrug resistance by ginsenoside Rg3 Biochem. Pharmacol.657582PubMedGoogle Scholar
  36. Kim, HS, Lee, EH, Ko, SR, Choi, KJ, Park, JH, Im, DS 2004Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cellsArch. Pharm. Res.27429435PubMedGoogle Scholar
  37. Kim, HE, Oh, JH, Lee, SK, Oh, YJ 1999dGinsenoside Rh2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathwayLife Sci.65PL3340Google Scholar
  38. Kimura M (1980) Hypoglycemic component in ginseng radix and its insulin release. Proceedings of the 3rd International Ginseng Symposium. Korean Ginseng Research Institut, Seoul, Korea.Google Scholar
  39. Kimura, I, Nakashima, N, Sugihara, Y, Fu-jun, C, Kimura, M 1999The antihyperglycaemic blend effect of traditional chinese medicine byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) micePhytother. Res.13484488CrossRefPubMedGoogle Scholar
  40. Kimura, M, Suzuki, J 1981The pattern of action of blended Chinese traditional medicines to glucose tolerance curves in genetically diabetic KK-CAy miceJ. Pharmacobiodyn.4907915PubMedGoogle Scholar
  41. Kimura, M, Waki, I, Chujo, T, Kikuchi, T, Hiyama, C, Yamazaki, K, Tanaka, O 1981aEffects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreasJ. Pharmacobiodyn.4410417Google Scholar
  42. Kimura, M, Waki, I, Tanaka, O, Nagai, Y, Shibata, S 1981bPharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radixJ. Pharmacobiodyn.4402409Google Scholar
  43. Kitagawa, I, Yoshikawa, M, Yoshihara, M, Hayashi, T, Taniyama, T 1983Chemical studies on crude drug procession. I. On theconstituents of Ginseng Radix RubraYakugaku Zasshi103612622PubMedGoogle Scholar
  44. Kobashi, K 1998Glycosides are natural prodrugs: Evidence using germfree and gnotobiotic rats associated with a human intestinal bacteriumJ. Trad. Med.15113Google Scholar
  45. Kudo, K, Tachikawa, E, Kashimoto, T, Takahashi, E 1998Properties of ginseng saponin inhibition of catecholamine secretion in bovine adrenal chromaffin cellsEur. J. Pharmacol.341139144CrossRefPubMedGoogle Scholar
  46. Kumar A (1993) Chemopreventive action of ginseng on DMBA-induced papillomagenesis in the skin of mice. Proc. 6th Intl. Ginseng Symp. (pp. 66–68).Google Scholar
  47. Kuo, SC, Teng, CM, Lee, JC, Ko, FN, Chen, SC, Huang, TF 1990Antiplatelet components in Panax ginseng Planta Med.56164167PubMedGoogle Scholar
  48. Lee KS (1980) Effect of ginseng saponin on the vascular smooth muscle. Proceedings of 3rd International Ginseng Symposium, pp. 71–76.Google Scholar
  49. Lee YH, Kim SI, Lee SK, Chung HY & Kim KW(1993). Differentiation mechanism of ginsenosides in cultured murine F9 teratocarcinoma stem cells. Proceedings of 6th International Ginseng Symposium, pp. 127–131.Google Scholar
  50. Lee, KY, Park, JA, Chung, E, Lee, YH, Kim, SI, Lee, SK 1996Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27 kip1Cancer Lett.110193200PubMedGoogle Scholar
  51. Lee, JY, Shin, JW, Chun, KS, Park, KK, Chung, WY, Bang, YJ, Sung, JH, Surh, YJ 2005Antitumor promotional effects of a novel intestinal bacterial metabolite(IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skinCarcinogenesis26359367PubMedGoogle Scholar
  52. Mochizuki, M, Yoo, YC, Matsuzawa, K, Sato, K, Saiki, I, Tonooka, S, Samikawa, K, Azuma, I 1995Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20 (R)- and 20 (S)-ginsenoside-Rg3, of red ginsengBiol. Pharm. Bull.1811971202PubMedGoogle Scholar
  53. Nakata, H, Kikuchi, Y, Tode, T, Hirata, J, Kita, T, Ishii, K, Kudoh, K, Nagata, I, Shinomiya, N 1998Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cellsJpn. J. Cancer Res.89733740PubMedGoogle Scholar
  54. Odani, T, Tanizawa, H, Takino, Y 1983Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the ratChem. Pharm. Bull. (Tokyo)3110591066Google Scholar
  55. Odashima, S, Ohta, T, Kohno, H, Matsuda, T, Kitagawa, I, Abe, H, Arichi, S 1985Control of phenotypic expression of cultured B16 melanoma cells by plant glycosidesCancer Res.4527812784PubMedGoogle Scholar
  56. Odashima, S, Ota, T, Fujikawa-Yamamoto, K, Abe, H 1989of phenotypic reverse transformation by plant glycosides in cultured cancerGan To Kagaku Ryoho1614831489PubMedGoogle Scholar
  57. Palmer, RM, Ashton, DS, Moncada, S 1988Vascular endothelial cells synthesize nitric oxide from l-arginineNature333664666CrossRefPubMedGoogle Scholar
  58. Park, JD 1996Recent studies on the chemical constituents of Korean ginseng (Panax ginseng CA. Meyer)Korean J. Ginseng Sci.20389415Google Scholar
  59. Park JD, Baek NI, Lee YH, Kim DS, Park JH, Ryu JH & Kim SI (1998) Four new dammarane-glycosides, ginsenosides Rg5, Rh4, Rs3 and Rf2 from Korean red ginseng, the root of Panax ginseng C. A. Meyer. Proceedings of the 7th International Symposium on ginseng, pp. 115–126.Google Scholar
  60. Park, MT, Cha, HJ, Jeong, JW, Kim, SI, Chung, HY, Kim, ND, Kim, OH, Kim, KW 1999Glucocorticoid receptor-induced down-regulation of MMP-9 by ginseng components, PD and PT contributes to inhibition of the invasive capacity of HT1080 human fibrosarcoma cellsMol. Cells9476483PubMedGoogle Scholar
  61. Park, JD, Kim, DS, Kwon, HY, Son, SK, Lee, YH, Baek, NI, Kim, SI, Rhee, DK 1996Effects of ginseng saponin on modulation of multidrug resistanceArch. Pharm. Res.19213218Google Scholar
  62. Popovich, DG, Kitts, DD 2002Structure–function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell lineArch. Biochem. Biophys.118Google Scholar
  63. Popovich, DG, Kitts, DD 2004Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.Can. J. Physiol. Pharmacol.82183190CrossRefPubMedGoogle Scholar
  64. Rapoport, RM, Murad, F 1983Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMPCirc. Res.52352357PubMedGoogle Scholar
  65. Sato, K, Mochizuki, M, Saiki, I, Yoo, YC, Samukawa, K, Azuma, I 1994Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2 Biol. Pharm. Bull.17635639PubMedGoogle Scholar
  66. Scott, GI, Colligan, PB, Ren, BH, Ren, J 2001Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: Role of nitric oxideBr. J. Pharmacol13411591165CrossRefPubMedGoogle Scholar
  67. Shibata, S 2001Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compoundsJ. Korean Med.16S2837Google Scholar
  68. Shinkai, K, Akedo, H, Mukai, M, Imamura, F, Isoai, A, Kobayashi, M, Kitagawa, I 1996Inhibition of in vitro tumor cell invasion by ginsenoside Rg3Jpn. J. Cancer Res.87357362PubMedGoogle Scholar
  69. Shibata, S, Fujita, M, Itokawa, H, Tanaka, O, Ishii, T 1963aStudies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol. A sapogenin of ginseng roots. (1)Chem. Pharm. Bull.11759761Google Scholar
  70. Shibata, S, Tanaka, O, Nagai, M, Ishii, T 1963bStudies on the constituents of Japanese and Chinese crude drugs. XII. Panaxadiol. A sapogenin of ginseng roots (2)Chem. Pharm. Bull.11762767Google Scholar
  71. Shibata S, Tanaka O, Shoji J & Saito H (1995) Chemistry and pharmacology of Panax. In: Economic and Medicinal Plant Research. Vol. 1. (pp. 217–284). Academic Press, New York.Google Scholar
  72. Sonnenborn, U, Proppert, Y 1990Ginseng (Panax ginseng C.A Meyer)Zeitschrift fur phytotherapie113549Google Scholar
  73. Suda, K, Murakami, K, Murata, J, Hasegawa, H, Saiki, I 2000Induction of apoptosis in Lewis lung carcinoma cells by an intestinal bacterial metabolite resulted from orally administered ginseng protopanaxadiol saponinsJ. Trad. Med.17236244Google Scholar
  74. Sung, J, Han, KH, Zo, JH, Park, HJ, Kim, CH, Oh, BH 2000Effects of red ginseng upon vascular endothelial function in patients with essential hypertensionAm. J. Chin. Med.28205216CrossRefPubMedGoogle Scholar
  75. Tatsuka, M, Maeda, M, Ota, T 2001Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh2 Jpn. J. Cancer Res.9211841189PubMedGoogle Scholar
  76. Teng, CM, Kuo, SC, Ko, FN, Lee, JC, Lee, LG, Chen, SC, Huang, TF 1989Antiplatelet actions of panaxynol and ginsenosides isolated from ginsengBiochim. Biophys. Acta.990315320PubMedGoogle Scholar
  77. Thompson, CB 1995Apoptosis in the pathogenesis and treatment of diseaseScience26714561462PubMedGoogle Scholar
  78. Tode, T, Kikuchi, Y, Hirata, J, Kita, T, Imaizumi, E, Nagata, I 1993Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serious cyst adenocarcinoma of the human ovaryNippon Sanka Fujinka Gakkai Zasshi4512751282PubMedGoogle Scholar
  79. Vane, JR, Anggard, EE, Botting, RM 1990Regulatory functions of the vascular endotheliumN. Engl. J. Med.3232736PubMedGoogle Scholar
  80. Vuksan, V, Sievenpiper, JL, Koo, VY, Francis, T, Beljan-Zdravkovic, U, Xu, Z, Vidgen, E 2000American ginseng (Panax quinquefolius L.) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitusArch. Intern. Med.16010091013CrossRefPubMedGoogle Scholar
  81. Wakabayashi, C, Murakami, K, Hasegawa, H, Murata, J, Saiki, I 1998An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cellsBiochem. Biophys. Res. Commun.246725730CrossRefPubMedGoogle Scholar
  82. Wu, XG, Zhu, DH, Li, X 2001Anticarcinogenic effect of red ginseng on the development of liver cancer induced by diethylnitrosamine in ratsJ. Korean Med.16S61S65Google Scholar
  83. Xia, LJ, Han, R 1996Differentiation of B16 melanoma cells induced by ginsenoside Rh2 Yao Xue Xue Bao31742745PubMedGoogle Scholar
  84. Yammamoto, M 1992Effects of administration of red ginseng on hypertension, normotension and hypotensionGinseng Rev.91520Google Scholar
  85. Yokozawa, T, Kobayashi, T, Oura, H, Kawashima, Y 1985Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic ratsChem Pharm. Bull. (Tokyo)3386972Google Scholar
  86. Yuan, CS, Attele, AS, Wu, JA, Lowell, TK, Gu, Z, Lin, Y 1999 Panax quinquefolium L. inhibits thrombin- induced endothelin release in vitroAm. J. Chin. Med.27331338CrossRefPubMedGoogle Scholar
  87. Yun, TK 2003Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compoundsMutat. Res.523–5246374PubMedGoogle Scholar
  88. Yun, TK, Lee, YS, Lee, YH, Kim, SI, Yun, HY 2001Anticarcinogenic effect of Panax ginseng C. A. Meyer and identification of active compoundsJ. Korean Med.16S6S18Google Scholar
  89. Yun, TK, Yun, TS, Han, IW 1983Anticarcinogenic effect of long-term oral administration of red ginseng on new born mice exposed to various chemical carcinogensCancer Detect. Prev.6515525PubMedGoogle Scholar
  90. Zhang, WJ, Wojta, J, Binder, BR 1997Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cella of human pulmonary arteryCell Mol. Biol.43581587PubMedGoogle Scholar
  91. Zhou, W, Chai, H, Lin, PH, Lumsden, AB, Yao, Q, Chen, CJ 2004Molecular mechanisms and clinical applications of ginseng root for cardiovascular diseaseMed. Sci. Monit.10RA187RA192PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Division of Ginseng ResearchKT&G Central Research InstituteTaejonKorea
  2. 2.College of PharmacySung Kyun Kwan UniversitySuwonKorea

Personalised recommendations